Time for a human interactome project?

FEATUREHuman Interactome Project An investment of $100 million should be enough to correlate the genome with function, and identify new basic research and drug targets BY MARC VIDAL© THOM GRAVESMapQuest and global positioning systems have radically changed the way we travel. By showing us where we are relative to where we want to go, these tools simplify the job of getting from point A to point B, and make trave

Written byMarc Vidal
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

An investment of $100 million should be enough to correlate the genome with function, and identify new basic research and drug targets

MapQuest and global positioning systems have radically changed the way we travel. By showing us where we are relative to where we want to go, these tools simplify the job of getting from point A to point B, and make travel in unfamiliar places less stressful. Some years ago I realized molecular biologists face an analogous problem: Cells contain tens of thousands of proteins and other macromolecules, which mediate hundreds of thousands of physical interactions at any given moment. Yet biologists lacked the navigational aids to traverse those interaction networks, aids that travelers today take for granted.

Early efforts to chart protein-protein interaction (or "interactome") networks, focused on defined biological processes in yeast and the worm, Caenorhabditis elegans; proteome-scale maps of yeast, worm, and the fly soon followed.1 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies